Jaringan Laboratorium Medis

Vol. 7 No. 1 (2025): May 2025
Original Articles

Difference of Platelet Count in Patients with Tuberculosis Before and After 1 Month of Treatment with Anti Tuberculosis Drug

PDF
  • Asa Taqarrasya,
  • Ririh Jatmi Wikandari,
  • Umi Rosidah
Asa Taqarrasya
Poltekkes Kemenkes Semarang
Ririh Jatmi Wikandari
Poltekkes Kemenkes Semarang
Umi Rosidah
Poltekkes Kemenkes Semarang

Published 2025-05-14

Keywords

  • Platelet Count ; Hematology ; Treatment ; Tuberculosis

Copyright (c) 2025 Jaringan Laboratorium Medis

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

How to Cite

Difference of Platelet Count in Patients with Tuberculosis Before and After 1 Month of Treatment with Anti Tuberculosis Drug. (2025). Jaringan Laboratorium Medis, 7(1), 69-75. https://doi.org/10.31983/jlm.v7i1.12798

CrossMark



Dimensions

If it doesn't Appear, click here



PlumX Metrics



Impact Factor

or, Visit on here

Abstract

Tuberculosis (TB) is still one of the infectious diseases with the highest mortality rate in the world. WHO stated that Indonesia is the third country in the world with the most TB cases. Semarang is the third province in Indonesia with the highest TB cases. Although the mortality rate is high, in reality TB can be treated and prevented. Anti-TB drugs as TB treatment agents can cause side effects, one of which is a decrease in the number of platelets. The purpose of this study was to determine the difference in the number of platelets in TB patients before starting treatment and after one month of treatment with Anti-TB drugs. The study population was new tuberculosis patients. The study sample was taken according to the established criteria and obtained as many as 24 people, who were examined twice, namely before treatment and after 1 month of treatment. The results of this study stated that the average number of platelets before starting TB treatment was 340.875 cells/μL and after one month of treatment with Anti-TB drugs was 281.958 cells/μL. The Wilcoxon test showed a P value = 0.009. There was a significant difference in the number of platelets before starting TB treatment and after one month of treatment with Anti-TB drugs. TB treatment can affect blood conditions, including platelets. Thus, patients and their families are expected to better  understand the importance of carrying out routine checks and not stopping treatment without medical consultation

PDF

Downloads

Download data is not yet available.

References

  1. Abulfathi, A. A., Decloedt, E. H., Svensson, E. M., Diacon, A. H., Donald, P., & Reuter, H. (2019). Clinical Pharmacokinetics and Pharmacodynamics of Rifampicin in Human Tuberculosis. Clinical Pharmacokinetics, 58(9), 1103–1129. https://doi.org/10.1007/s40262-019-00764-2
  2. Anggreani, N., Wulan, I., Sudarsono, Analisawati, Tantri, Wardani, K., Pratiwi, D., Rahaju, & Minto. (2023). Pengaruh Pemberian Obat Anti Tuberkulosis (OAT) Terhadap Jumlah Trombosit pada Pasien TB Paru di BKPM Purwokerto. Jurnal Surya Medika, 9(3), 92–100. https://doi.org/10.33084/jsm.v9i3.6473
  3. Dinas Kesehatan Kota Semarang. (2022). Dasbord Kesehatan Dinkes Kota Semarang 2022.pdf. Dinas Kesehatan. http://119.2.50.170:9095/dashboardNew/
  4. Dotulong. (2015). Hubungan faktor risiko umur, jenis kelamin, dan kepadatan hunian dengan kejadin TB paru di desa wori. Jurnal Kedokteran Tropik, 1(3), 1–10. https://ejournal.unsrat.ac.id/v2/index.php/JKKT/article/view/7773
  5. Durachim, A., & Astuti, D. (2018). Bahan Ajar Hemostasis. In Kementerian Kesehatan Republik Indonesia (Vol. 1, Issue 1, pp. 1–237). https://medlab.id/download-ebook-hemostasis/
  6. Isbaniah, F., Burhan, E., Sinaga, B. Y., Behtri, D., Yanifitri, Handayani, D., Harsini, Agustin, H., Artika, I. N., Aphridasari, J., Rohani Lasmaria, R., Soedarsono, Sugiri, & R., Y. J. (2021). Tuberkulosis Pedoman Diagnosis dan Penatalaksanaan di Indonesia. In Perhimpunan Dokter Paru Indonesia (Revisi 2, Vol. 001, Issue 2014). Perhimpunan Dokter Paru Indonesia. https://klikpdpi.com/bukupdpi/wp-content/uploads/2022/08/BUKU-GUIDELINE-TB-2021.pdf
  7. Kalma, K., Rafika, R., & Bahctiar, A. R. (2019). Platelet and Hemoglobin Concentration in Tuberculosis Patients With Anti-Tuberculosis Medication. Jurnal Media Analis Kesehatan, 10(2), 143. https://doi.org/10.32382/mak.v10i2.1302
  8. Karwiti, W., Sri Lestari, W., Rezekiyah, S., & Kesehatan Jambi, P. (2021). Perbedaan Profil Hematologi Pada Penderita Tuberkulosis Paru Yang Menjalani Pengobatan. Jambura Journal of Health Science and Research, 3(1), 126–132. https://doi.org/https://doi.org/10.35971/jjhsr.v3i1.8350
  9. Kementerian Kesehatan RI. (2020). Pedoman Nasional Pelayanan Kedokteran Tata Laksana Tuberkulosis. In Dirjen Pencegahan Pengendalian Penyakit (2020th ed., Vol. 11, Issue 1). Kemenkes RI.
  10. Kementerian Kesehatan RI. (2022). Rokok & TBC. https://p2ptm.kemkes.go.id/kegiatan-p2ptm/dki-jakarta/rokok-tbc-pengendalian-konsumsi-rokok-adalah-salah-satu-strategi-eliminasi-tuberkulosis
  11. Kirwan, D. E., Chong, D. L. W., & Friedland, J. S. (2021). Platelet Activation and the Immune Response to Tuberculosis. Frontiers in Immunology, 12(May), 1–11. https://doi.org/10.3389/fimmu.2021.631696
  12. Koumpis, E., Papathanasiou, K., Papakonstantinou, I., Tassi, I., Serpanou, A., Kapsali, E., & Hatzimichael, E. (2021). Rifampicin-Induced Thrombocytopenia: A Case Report and Short Review of the Literature. European Medical Journal, April. https://doi.org/10.33590/emj/20-00193
  13. Maharani, E. A., & Noviar, G. (2018). Bahan Ajar TLM Imunohematologi Dan Bank Darah. In Kemenkes RI (2018th ed., Vol. 11, Issue 1). Kemenkes RI. https://drive.google.com/file/d/1e1BHtyEoZDPhmIGbuYDFsCFlZW--2vtH/view
  14. Mandal, S. K., & Chavan. (2016). Hematological Profile in Patients Suffering From Tuberculosis and Treatment Response. Journal Of Medical Science And Clinical Research, 04(October), 13189–13192. https://www.jmscr.igmpublication.org/home/index.php/archive/91-volume-4-issue-10-oct-2016/1186-hematological-profile-in-patients-suffering-from-tuberculosis-and-treatment-response
  15. Nafsi, A. Y., & Rahayu, S. R. (2020). Analisis Spasial Tuberkulosis Paru Ditinjau dari Faktor Demografi dan Tingkat Kesejahteraan Keluarga di Wilayah Pesisir. Jurnal Penelitian Dan Pengembangan Kesehatan Masyarakat Indonesia, 1(1), 72–82. https://doi.org/10.15294/jppkmi.v1i1.41419
  16. Pradipta, I. S., Idrus, L. R., Probandari, A., Lestari, B. W., Diantini, A., Alffenaar, J. W. C., & Hak, E. (2021). Barriers and strategies to successful tuberculosis treatment in a high-burden tuberculosis setting: a qualitative study from the patient’s perspective. BMC Public Health, 21(1), 1–12. https://doi.org/10.1186/s12889-021-12005-y
  17. Ranucci, M., Aloisio, T., Dedda, U. Di, Menicanti, L., de Vincentiis, C., & Baryshnikova, E. (2019). Gender-based differences in platelet function and platelet reactivity to P2Y12 inhibitors. PLoS ONE, 14(11), 1–11. https://doi.org/10.1371/journal.pone.0225771
  18. Rosaline, M. D., & Herlina, S. (2021). Kami-Pmo Tb (Edukasi Dan Pendampingan Pengawas Menelan Obat Tb) Dalam Pengendalian Mdr Tb. Jurnal Bakti Masyarakat Indonesia, 3(2), 398–407. https://doi.org/10.24912/jbmi.v3i2.9475
  19. Wikandari, R. J., Surati, Nuryani, S., & Sistiyono. (2024). Hematological Profile of Pulmonary Tuberculosis Patients Before and After 1 Month of Taking Anti-TB Drugs. Jurnal Teknologi Laboratorium, 3(2), 135–144. https://doi.org/10.29238/teknolabjournal.v13i2.486
  20. World Health Organization, (WHO). (2021). Global Tuberculosis Report 2021. In (WHO) World Health Organization (Ed.), World Health Organization. World Health Organization. https://www.who.int/publications/i/item/9789240037021
  21. World Health Organization, (WHO). (2023). Global Tuberculosis Report 2023. In (WHO) World Health Organization (Ed.), January. https://iris.who.int/